Cemex
CX
9.59
-0.33
-3.33%
Cemex
US · CX
#1198 by market cap
Listed 1970
9.59
-0.33
-3.33%
Live - 5344 symbols - heartbeat 152s ago
· 2026-10-08 07:52
Pre-market
9.39
-2.09%
After-hours
9.59
0.00%
Overnight
9.58
-0.10%
- Market cap
- 13.84B
- P/E (TTM)i
- 29.97
- P/Bi
- 1.06
- EPSi
- 0.65
- Div yieldi
- 1.02%
- 52W posi
- 12%
Reader sentiment
Are you bullish or bearish on CX?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Barclays Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $16Market Newswire · 2026/7/24
-
Rating change
Scotiabank Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $14.5Market Newswire · 2026/7/24
-
Rating change
BofA Securities Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $14.75Market Newswire · 2026/7/7
-
Company notice
Zeta: ZETA and Channel Corporation have launched a business partnership in the generative AI space and begun service integration between the “ZETA CX Series” and “Channel Talk.”JPX · 2026/2/10
-
J.P. Morgan Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/9/2
-
Yomiuri: Mazda's New CX-5 Off to Great Start in Japan, but Struggling in U.S.Dow Jones · 2026/9/10
-
Company notice
IRidge: In the AI era, apps are shifting from “operation” to “conversation.” We’re now offering “NEW CX READY,” which enables ultra-fast real-world deployment of prototypes.JPX · 2026/1/29
-
Company notice
Mobilus: AI agent platform Vottia collaborates with Techmatic. AI utilizes CRM data in real time to automatically complete customer support and achieve both CX improvement and work efficiencyJPX · 2025/11/7
-
Rating change
RBC Capital Initiates Cemex(CX.US) With Hold Rating, Announces Target Price $13.5Market Newswire · 2026/7/24
-
FDA Says Aware Boston Scientific Issued Letter To Affected Customers Recommending Unused Infinion CX Leads Be Removed From Where They Are Used/Sold; As Of May 27, 2026, Boston Scientific Reported 1,081 Serious Injuries And No Deaths Associated With...Benzinga · 2026/9/4
-
Rating change
BofA Securities Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/7/24
-
Cemex(CX.US) Officer Sells US$8.88 Million in Common StockMarket Newswire · 2026/10/1
-
Goldman Sachs Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $15.5Market Newswire · 2026/8/5
-
Company notice
istyle: We have launched a “data-driven solution” to support data-driven decision-making in the beauty industry. A new company was established in collaboration with a CX consulting firmJPX · 2025/4/9
-
Company notice
Mobilus: FANCL uses Mobils' CX strategy support for the purpose of improving customer service satisfaction. LINE and web chat operations are self-propelled, and work time is reduced by one-third in collaboration with FAQJPX · 2025/2/13
-
Rating change
J.P. Morgan Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/7/8
-
Rating change
Barclays Maintains Cemex(CX.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/7/14
-
Rating change
RBC Capital Maintains Cemex(CX.US) With Hold Rating, Raises Target Price to $13.5Market Newswire · 2026/7/24
-
Rating change
Scotiabank Maintains Cemex(CX.US) With Buy Rating, Raises Target Price to $14.5Market Newswire · 2026/7/15
-
Rating change
Citi Maintains Cemex(CX.US) With Hold Rating, Raises Target Price to $13Market Newswire · 2026/7/4
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:52:24 · For reference only, not investment advice and not tailored to your situation.